Recent Developments in Food and Drug Law, 2014 ed.: Leading Lawyers on Dealing with Increased Enforcement, Keeping Up-To-Date with FDA Requirements, and Developing Compliance Practices (Inside the Minds)

Overview

Recent Developments in Food and Drug Law provides an authoritative, insider's perspective on adapting to major changes in FDA regulations and enforcement procedures. Featuring experienced partners from law firms across the nation, these experts guide the reader through the rise of FDA inspections and propose key strategies for helping clients manage compliance issues. These top lawyers offer advice on recognizing the triggers for investigations, responding to warning letters, and establishing an internal audit ...

See more details below
Other sellers (Paperback)
  • All (3) from $89.99   
  • New (2) from $89.99   
  • Used (1) from $89.99   
Sending request ...

More About This Book

Overview

Recent Developments in Food and Drug Law provides an authoritative, insider's perspective on adapting to major changes in FDA regulations and enforcement procedures. Featuring experienced partners from law firms across the nation, these experts guide the reader through the rise of FDA inspections and propose key strategies for helping clients manage compliance issues. These top lawyers offer advice on recognizing the triggers for investigations, responding to warning letters, and establishing an internal audit system. From navigating emerging trends in labeling practices to analyzing developments in pharmaceutical regulations, these experts emphasize the need to keep abreast of the FDA's increased safety concerns. The different niches represented and the breadth of perspectives presented enable readers to get inside some of the great legal minds of today, as these experienced lawyers offer up their thoughts on the keys to success within this dynamic area of law.

Inside the Minds provides readers with proven business and legal intelligence from leading C-Level executives and lawyers. Each chapter offers thought leadership and expert analysis on an industry, profession, or topic, providing a future-oriented perspective and proven strategies for success. Each author has been selected based on their experience and C-Level standing within the business and legal communities.

Chapters Include:

1. Bryan M. Haynes, Partner, Troutman Sanders LLP—"Understanding the Tobacco Control Act and FDA Investigative Process"
2. Ralph S. Tyler, Partner, Venable LLP—"Avoiding FDA Compliance Problems and Managing Them When They Occur"
3. David Abramowitz, Partner, Locke Lord LLP—"Keeping an Eye on FDA's Increased Focus on Safety and Efficacy"
4. Shahnam Sharareh, PharmD, JD, Partner, Fox Rothschild LLP—"New Food and Drug Law Enforcement Challenges: Where Do We Stand?"
5. Carey B. Nuttall, Partner, Patton Boggs LLP—"Pharmacy Compounding Issues in Today's Marketplace"
6. Brandon W. Neuschafer, Partner, Bryan Cave LLP—"Recent Developments in Food Labeling"
7. Roger Morris and Lisa Davis, Partners, Quarles & Brady LLP—"Generic Drugs and Biosimilars Lower Costs and Raise Legal Questions"
8. Theodora McCormick, Partner, Sills Cummis & Gross PC—"Food Advertising and Labeling Trends Spark Concerns About Compliance and Litigation"
9. Lisa Mueller, Partner, Michael Best & Friedrich—"Helping Clients Understand Biosimilar Product Regulations and the Biosimilar Litigation Process"
10. Suzan Onel, Partner, K&L Gates LLP—"Where the "App" World and FDA Collide: Current Status of the FDA's Regulation of Medical Device Software and Mobile Medical Apps"
11. Lauren A. Tulli, Member Attorney, Cozen O'Connor—"A Prescription for Responsibility: the FDA Looks to Expand the Scope of Potential Liability for Drug Company Officials"
12. Michael A. Walsh, Partner, Strasburger & Price LLP—"Net Impression: FDA's Old World Approach to a New World Opportunity"

Appendices Include:

Appendix A: Distributors—Have Your Suppliers Complied with the FDA's Registration and Filing Requirements?
Appendix B: FDA Issues "Guidance" on Exemptions from Substantial Equivalence Requirements
Appendix C: FDA Issues Draft Guidance on Demonstrating Substantial Equivalence
Appendix D: FDA Issues Draft Guidance on Applications for Premarket Review of New Tobacco Products
Appendix E: Lorillard Pursues FDA Citizen Petition to Obtain Approval of New Tobacco Products
Appendix F: Court Enjoins Law Requiring Graphic Cigarette Warnings
Appendix G: FDA Responds to Court Ruling on Graphic Warning Labels
Appendix H: Supreme Court Declines to Hear Challenge to FDA Graphic Warning Label Requirement
Appendix I: Congress Again Urges FDA to Regulate Cigars and Pipe Tobacco
Appendix J: Are Cigars with "Characterizing Flavors" Next on the Public Health Crusade's Hit List?
Appendix K: Obama Administration Includes New Tobacco Regulations in Regulatory Agenda
Appendix L: Current Good Manufacturing Practices—An Overlooked Requirement with Far Reaching Consequences
Appendix M: What is an Unacceptable Tobacco Brand Name Sponsorship Under FDA's Regulations?
Appendix N: FDA Issues Draft Guidance on Submission of Warning Plans for Cigarettes and Smokeless Tobacco Products
Appendix O: FDA Issues Draft Guidance on Submitting Applications for Modified Risk Tobacco Products
Appendix P: Federal Court Allows TPSAC Challenge to Proceed
Appendix Q: New Tobacco Czar Assumes the Reins at FDA
Appendix R: Compliance Policy Guides Manual: Sec. 460.200 Pharmacy Compounding
Appendix S: Pharmaceutical Compounding Quality and Accountability Act
Appendix T: Bipartisan HELP Senators Introduce Major Effort to Clarify Oversight of Compounding Pharmacies; Help Ensure Consumer Safety
Appendix U: Excerpts of Draft Guidance for Industry and Food and Drug Administration Staff: Mobile Medical Applications, July 21, 2011
Appendix V: Excerpt of FDA's Statement: Identifying an MDDS, April 19, 2011

Read More Show Less

Product Details

  • ISBN-13: 9780314291196
  • Publisher: Thomson Reuters Westlaw; Aspatore
  • Publication date: 11/1/2013
  • Pages: 312
  • Product dimensions: 5.50 (w) x 8.40 (h) x 0.80 (d)

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)